Eva Pharma is one of the leading and fastest growing pharmaceutical manufacturers in the MENA region, with a 30%+ CAGR over the past five years. It is a branded generics powerhouse which also operates in OTC and food supplements. Eva Pharma has a portfolio of over 126 products; covering various therapeutic classes including Neurology, Psychiatry, Cardiovascular, Orthopedics, GIT, Pediatrics, Urology and Dermatology. The company has its own sales teams in many countries of the MENA region including Egypt, KSA, UAE, Bahrain, Qatar, Oman, Kuwait, Iraq, Lebanon, Yemen, Kenya, Libya & Ethiopia. Its distinctive state-of-the-art manufacturing facility in Cairo is approved by EMA, SFDA & GCC authorities allowing it to be a contract manufacturer for some of the leading companies in the globe. Eva Pharma is led by a distinctive team of professionals with a forward thinking philosophy, it continues to add local and international manufacturing facilities wherever opportunities arise and is growing strategically to ensure its high quality affordable products are available for all.
Contact
Armanious Group Tower, 9 El Sharekat Street, Opera – Abdeen, Cairo, Egypt
P.O. Box: 1002 & 845
Postal code: 11518
BD’s Loay Badr outlines the rationale behind the medtech giant’s recent establishment of a direct presence in Egypt, the significant opportunities for medical device players in the country as it…
Country President, Hatem Werdany, provides an overview of AstraZeneca’s 50+ year legacy in Egypt and outlines the company’s plans to launch up to 25 new products there over the next…
Boehringer Ingelheim’s Marianne Abou Elkheir, General Manager and Head of Human Pharma for Levant, Iraq and North-East Africa (LINEA) and Sub-Saharan Africa (SSA), walks us through her career trajectory and…
As Egypt moves towards universal healthcare coverage for its 100 million-plus population, the country has become the fastest growing pharma market in the Middle East and Africa region with a…
Dr Amel El Beshlawy, founder of Egyptian Thalassemia Association (ETA) and Professor of Pediatric Hematology at the Pediatric Hospital of Cairo University, is considered the Middle East’s leading authority on…
PhRMA’s Middle East & Africa (MEA) group appoints a ‘champion’ for each of its markets to bring the priorities of that country to the agenda of the MEA executive committee.…
Sherif Amin, an 18-year industry veteran with 12 years of experience in oncology leadership roles across MEA, is the recipient of several awards, including the 2019 Oncology President Award, 2015…
Back in June 2022, Pfizer signed a memorandum of understanding (MoU) with the Egyptian Ministry of Health (MoH) to transfer the technology for producing its pneumococcal vaccine. The fifth highest…
Internationally renowned healthcare quality and safety expert Dr Ashraf Ismail explains the concept behind the Egyptian General Authority for Healthcare Accreditation and Regulation (GAHAR), its work in setting and implementing…
Under the auspices of a wide-ranging Vision 2030 economic transformation plan, Egypt is moving towards covering the entirety of its 100 million plus population under a universal healthcare insurance scheme.…
Pfizer’s general manager for Egypt, Ahmed El-Shazly, comments on his return to Egypt after 19 years away, the significant opportunities ahead for the affiliate as it looks to find its…
Mohamed Ali Abd El Azim gives several insights into GSK’s sizeable production footprint in Egypt, how the organisation’s aims dovetail with Egypt’s healthcare transformation, and what makes him proud to…
See our Cookie Privacy Policy Here
